Reversal of social deficits by subchronic oxytocin in two autism mouse models
Open Access
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 105, 61-71
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War (AR1002312P1, AR1002312P2, AR100231P3)
- National Institute of Mental Health (K01 MH094406, RO1 MH080069)
- National Institute of Child Health and Human Development (7952, P30 HD03110, U54 HD079124)
This publication has 71 references indexed in Scilit:
- Effects of intranasal oxytocin on social anxiety in males with fragile X syndromePsychoneuroendocrinology, 2012
- Rewards, aversions and affect in adolescence: Emerging convergences across laboratory animal and human dataDevelopmental Cognitive Neuroscience, 2011
- Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related DeficitsCell, 2011
- Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia PatientsBiological Psychiatry, 2010
- Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strainBehavioural Brain Research, 2010
- Social approach and repetitive behavior in eleven inbred mouse strainsBehavioural Brain Research, 2008
- Development of a mouse test for repetitive, restricted behaviors: Relevance to autismBehavioural Brain Research, 2008
- Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assaysJournal of Neural Transmission, 2008
- Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strainsBehavioural Brain Research, 2007
- Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunctionPharmacology Biochemistry and Behavior, 2006